Illumina has lodged an appeal at the EU courts contesting the European Commission’s assertion of jurisdiction over its non-notifiable Grail deal, the company announced today (see here).
The appeal was lodged yesterday evening, and the company has asked for the expedited procedure, MLex has learned.*
The US gene-sequencing company is challenging the